PALO ALTO, Calif.--(BUSINESS WIRE)--Q Bio Inc., an innovator in medical imaging technology, today announced the launch of Tensor Field Mapping (TFM), a new technology for Magnetic Resonance Imaging (MRI) that provides detailed insights into the human body that were previously unimaginable. Unlike traditional MRIs that provide qualitative data prone to machine or clinical variations, TFM delivers quantitative, harmonized imaging data that can be immediately accessed by AI to accelerate diagnostics. "For decades, MRI technology has been invaluable in diagnosing a wide range of medical conditions, yet it has been limited by its qualitative nature and the variability of the data," said Jeff Kaditz, Founder and CTO / CEO, Q Bio. "With the introduction of Tensor Field Mapping, we are taking a quantum leap forward, making multi-parametric quantification of tissues reproducible across machines, which is key to AI in MRI and personalized medicine.". TFM is the result of extensive research and development by Q Bio's team of experts in medical imaging, physics, and computational science, and will make its debut in the company’s upcoming Mark I full body scanner. The technology provides quantifiable data lacking in traditional MRIs so that properties of tissues can be measured and benchmarked on an ongoing basis

Medical imaging company Q Bio announced the launch of a multiparametric MRI upgrade, dubbed Tensor Field Mapping (TFM), designed to provide more detail into the inner-workings of the human body than are currently possible with an MR scanner.

Q Bio launches multiparametric MRI quantification softwre.